National Institutes of Health halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms

The Clinical Trial of COVID-19 Convalescent Plasma of Outpatients (C3PO) study, which was evaluating convalescent plasma in people with mild symptoms for ≤1 week, was stopped after an independent data and safety monitoring board concluded it was unlikely to offer any benefit.

Source:

National Institutes of Health